Constantine Davides
Stock Analyst at Citizens
(0.96)
# 3,920
Out of 5,182 analysts
121
Total ratings
28.57%
Success rate
-22.7%
Average return
Main Sectors:
Stocks Rated by Constantine Davides
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMDA Omada Health | Initiates: Market Outperform | $18 | $14.72 | +22.28% | 1 | Apr 14, 2026 | |
| AMN AMN Healthcare Services | Maintains: Market Outperform | $22 → $24 | $20.98 | +14.39% | 14 | Feb 23, 2026 | |
| PGNY Progyny | Upgrades: Market Outperform | $30 | $18.41 | +62.95% | 4 | Jan 20, 2026 | |
| OPCH Option Care Health | Reiterates: Market Outperform | $36 → $38 | $27.93 | +36.05% | 8 | Jan 13, 2026 | |
| EVH Evolent Health | Maintains: Market Outperform | $11 → $10 | $3.47 | +188.18% | 12 | Jan 6, 2026 | |
| HQY HealthEquity | Maintains: Market Outperform | $117 → $122 | $83.47 | +46.16% | 6 | Dec 4, 2025 | |
| PRVA Privia Health Group | Maintains: Market Outperform | $30 → $31 | $24.41 | +27.00% | 5 | Nov 7, 2025 | |
| OPRX OptimizeRx | Maintains: Market Outperform | $23 → $24 | $6.41 | +274.41% | 11 | Nov 7, 2025 | |
| WAY Waystar Holding | Initiates: Market Outperform | $48 | $25.70 | +86.77% | 1 | Sep 18, 2025 | |
| ADUS Addus HomeCare | Reiterates: Market Outperform | $150 | $98.14 | +52.84% | 4 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $14.61 | - | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $6.24 | - | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $25.32 | - | 4 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $113 | $73.19 | +54.39% | 2 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $20 → $26 | $39.39 | -33.99% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $225 → $248 | $175.30 | +41.47% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $21.43 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $10.30 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $5.25 | $1.25 | +320.00% | 3 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $0.90 | +13,788.89% | 5 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $26.00 | -42.31% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $23.36 | -3.68% | 4 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.5 | $3.26 | +160.74% | 2 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $0.78 | +1,694.87% | 4 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $360 | $0.44 | +81,904.56% | 4 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3,240 | $1.38 | +234,682.61% | 3 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $40 | $0.69 | +5,697.10% | 2 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.14 | +4,305.29% | 2 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,400 → $800 | $1.59 | +50,214.47% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $597,600 → $298,800 | $2.23 | +13,399,003.14% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $85 | $0.12 | +68,949.55% | 2 | Sep 23, 2022 |
Omada Health
Apr 14, 2026
Initiates: Market Outperform
Price Target: $18
Current: $14.72
Upside: +22.28%
AMN Healthcare Services
Feb 23, 2026
Maintains: Market Outperform
Price Target: $22 → $24
Current: $20.98
Upside: +14.39%
Progyny
Jan 20, 2026
Upgrades: Market Outperform
Price Target: $30
Current: $18.41
Upside: +62.95%
Option Care Health
Jan 13, 2026
Reiterates: Market Outperform
Price Target: $36 → $38
Current: $27.93
Upside: +36.05%
Evolent Health
Jan 6, 2026
Maintains: Market Outperform
Price Target: $11 → $10
Current: $3.47
Upside: +188.18%
HealthEquity
Dec 4, 2025
Maintains: Market Outperform
Price Target: $117 → $122
Current: $83.47
Upside: +46.16%
Privia Health Group
Nov 7, 2025
Maintains: Market Outperform
Price Target: $30 → $31
Current: $24.41
Upside: +27.00%
OptimizeRx
Nov 7, 2025
Maintains: Market Outperform
Price Target: $23 → $24
Current: $6.41
Upside: +274.41%
Waystar Holding
Sep 18, 2025
Initiates: Market Outperform
Price Target: $48
Current: $25.70
Upside: +86.77%
Addus HomeCare
Jul 16, 2025
Reiterates: Market Outperform
Price Target: $150
Current: $98.14
Upside: +52.84%
Jun 18, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $14.61
Upside: -
May 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $6.24
Upside: -
Apr 28, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $25.32
Upside: -
Apr 22, 2025
Reiterates: Market Outperform
Price Target: $113
Current: $73.19
Upside: +54.39%
Feb 26, 2025
Maintains: Market Outperform
Price Target: $20 → $26
Current: $39.39
Upside: -33.99%
Feb 26, 2025
Maintains: Market Outperform
Price Target: $225 → $248
Current: $175.30
Upside: +41.47%
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $21.43
Upside: -
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $10.30
Upside: -
Jun 1, 2023
Assumes: Buy
Price Target: $5.25
Current: $1.25
Upside: +320.00%
May 16, 2023
Reiterates: Buy
Price Target: $125
Current: $0.90
Upside: +13,788.89%
May 11, 2023
Reiterates: Buy
Price Target: $15
Current: $26.00
Upside: -42.31%
May 10, 2023
Reiterates: Buy
Price Target: $23
Current: $23.36
Upside: -3.68%
May 5, 2023
Reiterates: Buy
Price Target: $8.5
Current: $3.26
Upside: +160.74%
Apr 27, 2023
Reiterates: Buy
Price Target: $14
Current: $0.78
Upside: +1,694.87%
Apr 19, 2023
Reiterates: Buy
Price Target: $360
Current: $0.44
Upside: +81,904.56%
Apr 13, 2023
Reiterates: Buy
Price Target: $3,240
Current: $1.38
Upside: +234,682.61%
Apr 3, 2023
Maintains: Buy
Price Target: $46 → $40
Current: $0.69
Upside: +5,697.10%
Mar 16, 2023
Reiterates: Buy
Price Target: $6
Current: $0.14
Upside: +4,305.29%
Sep 28, 2022
Maintains: Buy
Price Target: $1,400 → $800
Current: $1.59
Upside: +50,214.47%
Sep 28, 2022
Maintains: Buy
Price Target: $597,600 → $298,800
Current: $2.23
Upside: +13,399,003.14%
Sep 23, 2022
Maintains: Buy
Price Target: $110 → $85
Current: $0.12
Upside: +68,949.55%